APDN
Applied DNA Sciences Inc
$
0.837
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
0.837601
Open
0.7923
VWAP
0.81
Vol
727.05K
Mkt Cap
5.44M
Low
0.7902
Amount
588.76K
EV/EBITDA(TTM)
--
Total Shares
9.01M
EV
-4.35M
EV/OCF(TTM)
--
P/S(TTM)
2.44
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
1.63M
+99.97%
--
--
1.28M
+60%
--
--
1.19M
+27.47%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Applied DNA Sciences, Inc. (APDN) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -90.01%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-90.01%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Applied DNA Sciences Inc (APDN.O) is -0.04, compared to its 5-year average forward P/E of -3.23. For a more detailed relative valuation and DCF analysis to assess Applied DNA Sciences Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-3.23
Current PE
-0.04
Overvalued PE
-0.14
Undervalued PE
-6.33
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
2.38
Current PS
0.93
Overvalued PS
4.02
Undervalued PS
0.74
Financials
Annual
Quarterly
FY2025Q1
YoY :
+34.28%
1.20M
Total Revenue
FY2025Q1
YoY :
-21.77%
-2.96M
Operating Profit
FY2025Q1
YoY :
+136.11%
-2.67M
Net Income after Tax
FY2025Q1
YoY :
-67.63%
-0.56
EPS - Diluted
FY2025Q1
-3.44M
Free Cash Flow
FY2025Q1
YoY :
+120.48%
57.17
Gross Profit Margin - %
FY2025Q1
N/A
FCF Margin - %
FY2025Q1
YoY :
+75.84%
-223.02
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
60.3K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
2
216.0K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
APDN News & Events
Events Timeline
2025-04-21 (ET)
2025-04-21
09:06:25
Applied DNA's LineaRx 'ready to support' reshoring of drug development
2025-04-08 (ET)
2025-04-08
09:09:37
Applied DNA regains compliance with Nasdaq minimum bid price rule
2025-04-01 (ET)
2025-04-01
09:48:38
Applied DNA positions TR8 PGx testing as pre-emptive for therapeutic safety
Sign Up For More Events
Sign Up For More Events
News
5.0
04-01BenzingaWhy Applied DNA Sciences (APDN) Stock Is Rising
9.0
03-26SeekingAlphaApplied DNA seeks NY bird flu test approval
8.0
02-27SeekingAlphaWHO maintains public health emergency alert on mpox
Sign Up For More News
People Also Watch
AAPL
Apple Inc
212.330
USD
-0.28%
TSLA
Tesla Inc
347.680
USD
+4.07%
MSFT
Microsoft Corp
452.940
USD
+0.85%
NVDA
NVIDIA Corp
135.340
USD
+4.16%
META
Meta Platforms Inc
659.360
USD
+0.51%
AVGO
Broadcom Inc
232.120
USD
-0.13%
AMZN
Amazon.com Inc
210.250
USD
-0.53%
ORCL
Oracle Corp
162.950
USD
+0.42%
WMT
Walmart Inc
96.830
USD
+0.99%
XOM
Exxon Mobil Corp
108.480
USD
-0.90%
FAQ
What is Applied DNA Sciences Inc (APDN) stock price today?
The current price of APDN is 0.8367 USD — it has increased 5.55 % in the last trading day.
What is Applied DNA Sciences Inc (APDN)'s business?
What is the price predicton of APDN Stock?
What is Applied DNA Sciences Inc (APDN)'s revenue for the last quarter?
What is Applied DNA Sciences Inc (APDN)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Applied DNA Sciences Inc (APDN)'s fundamentals?
How many employees does Applied DNA Sciences Inc (APDN). have?